Meir Medical Center Rheumatologic Biobank
NCT03473912 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-03-11
Summary
Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research, following approval of each specific study by the IRB. The investigators intend to extract protein, DNA and RNA from each sample.
Conditions
- Rheumatoid Arthritis
- Lupus Erythematosus, Systemic
- Systemic Sclerosis
- IgG4-related Disease
- Sjogren's Syndrome
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Principal Investigators
-
Yair Levy, Prof. · Meir Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-16
- Primary Completion
- 2037-11-30
- Completion
- 2037-11-30
Countries
- Israel
Study Locations
More Related Trials
-
COVID-19 Vaccination in Rheumatic Disease Patients
NCT04839315 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
NCT01593332 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor
NCT02079532 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
NCT00443651 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients
NCT03016884 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases
NCT05026892 ·Status: UNKNOWN
-
RHYTHM (Formerly Escape II Myocardium)
NCT01548768 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)
NCT01075477 ·Status: COMPLETED
-
RESTART C0168Z05 Rheumatoid Arthritis Study
NCT00714493 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Rituximab on the Humoral Response to Influenza Vaccine
NCT00466037 ·Status: TERMINATED ·Phase: NA
-
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01232569 ·Status: COMPLETED ·Phase: PHASE3
-
Stem Cell Support in Patients With Rheumatoid Arthritis
NCT00278551 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
NCT01251120 ·Status: TERMINATED ·Phase: PHASE4
-
Rituximab in Rheumatoid Arthritis Lung Disease
NCT00578565 ·Status: COMPLETED ·Phase: PHASE3
-
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
NCT04584541 ·Status: TERMINATED ·Phase: NA
-
Intraarticular Injection of Infliximab
NCT00521963 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis
NCT01715896 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response
NCT02240888 ·Status: COMPLETED ·Phase: NA
-
Dissecting the Cellular and Molecular Atlas of Rheumatoid Arthritis in Sustained Remission to Identify Pathways Maintaining Remission and Triggering Flares
NCT05952440 ·Status: RECRUITING
-
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
NCT05879419 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
INCMNSZ - Rheumatoid Arthritis Cohort
NCT03389711 ·Status: UNKNOWN
-
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis
NCT01244958 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate
NCT00845832 ·Status: TERMINATED ·Phase: PHASE2
-
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
NCT00116714 ·Status: COMPLETED
-
JAK-i on RA B-lymphocytes Tolerance and Disease Resolution Through JAK Signaling In Rheumatoid Arthritis
NCT05754112 ·Status: UNKNOWN